1983
DOI: 10.1016/0002-9378(83)90822-0
|View full text |Cite
|
Sign up to set email alerts
|

Alterations of maternal metabolism in normal and diabetic pregnancies: Differences in insulin-dependent, non-insulin-dependent, and gestational diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
35
0

Year Published

1996
1996
2007
2007

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 78 publications
(37 citation statements)
references
References 30 publications
2
35
0
Order By: Relevance
“…These results are consistent with clinical and experimental observations that estrogen excesses, as in pregnancy [2,3], trans-sexuality [4], and during menstrual cycles [5], or estrogen deficiencies as in aromatase deficient [6] and OVX animals [7], cause insulin resistance. Moreover, a selective ER-α antagonist, MPP, diminished the beneficial effect of E2 at 10 -8 M on glucose uptake.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…These results are consistent with clinical and experimental observations that estrogen excesses, as in pregnancy [2,3], trans-sexuality [4], and during menstrual cycles [5], or estrogen deficiencies as in aromatase deficient [6] and OVX animals [7], cause insulin resistance. Moreover, a selective ER-α antagonist, MPP, diminished the beneficial effect of E2 at 10 -8 M on glucose uptake.…”
Section: Discussionsupporting
confidence: 90%
“…In clinical studies, high concentrations of estrogens, as in pregnancy [2,3], trans-sexuality [4] and during menstrual cycles [5], appear to contribute to the development of insulin resistance. On the other hand, there is considerable evidence against adverse effects of estrogens on glucose metabolism and some for beneficial actions of estrogen.…”
mentioning
confidence: 99%
“…In contrast, women who develop gestational diabetes or who have Type II diabetes during pregnancy exhibit the same degree of insulin resistance in the late stages of pregnancy, but a lower insulin secretory response, than do nondiabetic women [10]. As a result, the intrauterine environment in gestational diabetes is characterized by increased concentrations of glucose, amino acids and lipids in the maternal circulation, greater delivery of these nutrients to the fetus, raised fetal insulin secretion, and accelerated fetal growth [11,12]. Because differentiation of adipose tissue and storage of triglycerides begins during the third trimester of pregnancy [13], the effect of diabetes at this point in fetal development is to hasten the accumulation of fat in the fetus and results in infants that are both heavier and fatter than infants born to nondiabetic women [14].…”
Section: : 1157±1162]mentioning
confidence: 99%
“…Gestational diabetes mellitus (GDM) occurs in 2 ± 4% of all pregnancies and is characterized by a pronounced decrease in insulin sensitivity and an insuf®cient insulin secretion leading to abnormal glucose tolerance during pregnancy (Hollingsworth, 1983;Buchanan et al, 1990;National Diabetes Data Group, 1979;American Diabetes Association, 1993;Ku Èhl, 1975;Ku Èhl et al, 1984). The advantage of a high-carbohydrate, low-fat diet in treatment of type 2 diabetes has been questioned, due to carbohydrate-induced increase of triacylglycerol concentrations (American Diabetes Association, 1987;Medical Advisory Committee, 1982;Pedersen O, 1994;Coulston et al, 1987Coulston et al, , 1988.…”
Section: Introductionmentioning
confidence: 99%